Literature DB >> 33082563

RNA in cancer.

Gregory J Goodall1,2,3, Vihandha O Wickramasinghe4,5.   

Abstract

While the processing of mRNA is essential for gene expression, recent findings have highlighted that RNA processing is systematically altered in cancer. Mutations in RNA splicing factor genes and the shortening of 3' untranslated regions are widely observed. Moreover, evidence is accumulating that other types of RNAs, including circular RNAs, can contribute to tumorigenesis. In this Review, we highlight how altered processing or activity of coding and non-coding RNAs contributes to cancer. We introduce the regulation of gene expression by coding and non-coding RNA and discuss both established roles (microRNAs and long non-coding RNAs) and emerging roles (selective mRNA processing and circular RNAs) for RNAs, highlighting the potential mechanisms by which these RNA subtypes contribute to cancer. The widespread alteration of coding and non-coding RNA demonstrates that altered RNA biogenesis contributes to multiple hallmarks of cancer.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33082563     DOI: 10.1038/s41568-020-00306-0

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  221 in total

Review 1.  A day in the life of the spliceosome.

Authors:  A Gregory Matera; Zefeng Wang
Journal:  Nat Rev Mol Cell Biol       Date:  2014-02       Impact factor: 94.444

Review 2.  Control of mammalian gene expression by selective mRNA export.

Authors:  Vihandha O Wickramasinghe; Ronald A Laskey
Journal:  Nat Rev Mol Cell Biol       Date:  2015-06-17       Impact factor: 94.444

Review 3.  A network-biology perspective of microRNA function and dysfunction in cancer.

Authors:  Cameron P Bracken; Hamish S Scott; Gregory J Goodall
Journal:  Nat Rev Genet       Date:  2016-10-31       Impact factor: 53.242

Review 4.  Transcriptional Addiction in Cancer.

Authors:  James E Bradner; Denes Hnisz; Richard A Young
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

Review 5.  Mechanistic insights into precursor messenger RNA splicing by the spliceosome.

Authors:  Yigong Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2017-09-27       Impact factor: 94.444

Review 6.  Alternative cleavage and polyadenylation in health and disease.

Authors:  Andreas J Gruber; Mihaela Zavolan
Journal:  Nat Rev Genet       Date:  2019-07-02       Impact factor: 53.242

7.  The Landscape of Circular RNA in Cancer.

Authors:  Josh N Vo; Marcin Cieslik; Yajia Zhang; Sudhanshu Shukla; Lanbo Xiao; Yuping Zhang; Yi-Mi Wu; Saravana M Dhanasekaran; Carl G Engelke; Xuhong Cao; Dan R Robinson; Alexey I Nesvizhskii; Arul M Chinnaiyan
Journal:  Cell       Date:  2019-02-07       Impact factor: 41.582

8.  RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing.

Authors:  Heidi Dvinge; Jamie Guenthoer; Peggy L Porter; Robert K Bradley
Journal:  Genome Res       Date:  2019-08-21       Impact factor: 9.043

9.  Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia.

Authors:  Eric Wang; Sydney X Lu; Alessandro Pastore; Xufeng Chen; Jochen Imig; Stanley Chun-Wei Lee; Kathryn Hockemeyer; Yohana E Ghebrechristos; Akihide Yoshimi; Daichi Inoue; Michelle Ki; Hana Cho; Lillian Bitner; Andreas Kloetgen; Kuan-Ting Lin; Taisuke Uehara; Takashi Owa; Raoul Tibes; Adrian R Krainer; Omar Abdel-Wahab; Iannis Aifantis
Journal:  Cancer Cell       Date:  2019-02-21       Impact factor: 31.743

Review 10.  RNA and disease.

Authors:  Thomas A Cooper; Lili Wan; Gideon Dreyfuss
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

View more
  232 in total

1.  Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma.

Authors:  Ulrich H Weidle; Tatjana Sela; Ulrich Brinkmann; Jens Niewoehner
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

2.  LncRNA CEBPA-AS1 knockdown prevents neuronal apoptosis against oxygen glucose deprivation/reoxygenation by regulating the miR-455/GPER1 axis.

Authors:  Jun Peng; Zheng-Tao Yu; Rong-Jun Xiao; Qing-Song Wang; Ying Xia
Journal:  Metab Brain Dis       Date:  2022-01-28       Impact factor: 3.584

Review 3.  Tumor immune microenvironment lncRNAs.

Authors:  Eun-Gyeong Park; Sung-Jin Pyo; Youxi Cui; Sang-Ho Yoon; Jin-Wu Nam
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

4.  Side effect prediction based on drug-induced gene expression profiles and random forest with iterative feature selection.

Authors:  Arzu Cakir; Melisa Tuncer; Hilal Taymaz-Nikerel; Ozlem Ulucan
Journal:  Pharmacogenomics J       Date:  2021-06-21       Impact factor: 3.550

Review 5.  The role of RNA processing and regulation in metastatic dormancy.

Authors:  Kimberly A Parker; Nathaniel J Robinson; William P Schiemann
Journal:  Semin Cancer Biol       Date:  2021-03-26       Impact factor: 15.707

Review 6.  The regulation of RNA metabolism in hormone signaling and breast cancer.

Authors:  Xiaofei Wang; Da Yang
Journal:  Mol Cell Endocrinol       Date:  2021-03-10       Impact factor: 4.102

7.  High expression of aldolase A is associated with tumor progression and poor prognosis in hepatocellular carcinoma.

Authors:  Yan Tang; Xuefeng Yang; Kehai Feng; Changlu Hu; Suyi Li
Journal:  J Gastrointest Oncol       Date:  2021-02

8.  A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer.

Authors:  Xuan Deng; Fanyang Kong; Si Li; Haoqin Jiang; Liu Dong; Xiao Xu; Xinju Zhang; Hong Yuan; Ying Xu; Yimin Chu; Haixia Peng; Ming Guan
Journal:  Cell Death Dis       Date:  2021-05-13       Impact factor: 8.469

9.  miR-1258 Attenuates Tumorigenesis Through Targeting E2F1 to Inhibit PCNA and MMP2 Transcription in Glioblastoma.

Authors:  Hongkun Qin; Yanping Gui; Rong Ma; Heng Zhang; Yabing Guo; Yuting Ye; Jia Li; Li Zhao; Yajing Wang
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

10.  circRNA-TBC1D4, circRNA-NAALAD2 and circRNA-TGFBR3: Selected Key circRNAs in Neuroblastoma and Their Associations with Clinical Features.

Authors:  Weihong Lin; Zuopeng Wang; Jing Wang; Hanlei Yan; Qilei Han; Wei Yao; Kai Li
Journal:  Cancer Manag Res       Date:  2021-05-28       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.